DeciBio
Asavari Tiku is a skilled professional with a background in neuroscience and extensive experience in research and analysis. Currently serving as a Senior Associate at DeciBio since March 2023, Asavari previously held positions as an Associate and Senior Analyst within the same company. Prior experience includes work as a Life Sciences Analyst at DeciBio, a Research Project Lead at the David Geffen School of Medicine at UCLA, where a first-author paper on visual cortex neuron development was published, and a Research Assistant focusing on thalamocortical signal integration at UCLA. Additional roles include Gallery Assistant at the Hammer Museum, providing visitor services, and Workshops Director at Active Minds, Inc., managing innovative workshops on mental health. Asavari holds a Bachelor of Science in Neuroscience from UCLA.
DeciBio
1 followers
DeciBio Consulting is a boutique strategy consulting firm focusing on the life science industry. DeciBio's mission is to provide the strategic insights that accelerate the development, adoption, and accessibility of personalized medicine. Headquartered in Los Angeles, CA, DeciBio serves clients and customers across the globe, ranging from incubator-stage startups to Fortune 500 life science corporations. DeciBio addresses business solutions that range from market landscape analyses to full commercial strategies, including organic and inorganic growth opportunities (commercial due diligences). DeciBio’s work is typically supported by a mix of primary and secondary research leveraging Dexter, its in-house expert network, and DeciBio Analytics’ proprietary data intelligence products. DeciBio’s Analytics division offers numerous data products to support strategic insights, including in clinical diagnostics (the DxBooks), immuno-oncology (the I/O BioMAP), omics market segmentation (the MarketBooks), and the entire life sciences industry (BioTrack). Internal teams such as the Culture Committee, Women* in Consulting, and Gays in Consulting enrich the employee experience. DeciBio’s Social Impact board and the DeciBio Impact Lab work collaboratively across divisions and externally to uproot discrimination and increase access to precision medicine.